{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicyxz6iqzbwmxjrhnazqujepy7s4znofyn62vke24t5j7mbcwjqra",
    "uri": "at://did:plc:6pwit4ctv4egvys3qyqmgbi6/app.bsky.feed.post/3mnd4gnktvk42"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreieeou37jzej5eapeux44ohkotg64gdulkyl3xumlh2lucuyamyrre"
    },
    "mimeType": "image/webp",
    "size": 8966
  },
  "path": "/health/could-cancer-vaccines-next-new-treatment-cuts-melanoma-risk-nearly-50",
  "publishedAt": "2026-06-02T17:03:32.000Z",
  "site": "https://www.foxnews.com",
  "tags": [
    "651fcaa4-651e-521f-9a99-a4755a405f8b",
    "fnc",
    "Fox News",
    "fox-news/health",
    "fox-news/health/cancer",
    "fox-news/health/cancer/skin-cancer",
    "fox-news/health/infectious-disease/vaccines",
    "fox-news/health/medical-research",
    "fox-news/lifestyle",
    "fox-news/health/healthy-living/medications",
    "article"
  ],
  "textContent": "A new mRNA melanoma vaccine from Merck and Moderna showed sustained benefits over five years, cutting the risk of cancer recurrence or death by nearly half.",
  "title": "Could cancer vaccines be next? New treatment cuts melanoma risk by nearly 50%"
}